Tokyo Guidelines Cholangitis Severity (TG18)

ورودی‌های بالینی بیمار

پنل نتیجه و تصمیم بالینی
در انتظار ورودی‌ها
severity grade
—grade
آماده برای ارزیابی

پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.

طبقات خطر و بازه‌های امتیاز:
  • Grade I (mild)1–1
  • Grade II (moderate)2–2
  • Grade III (severe)3–3
Direct Clinical Answer

The Tokyo Guidelines Cholangitis Severity (TG18) calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include organ cardiovascular. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.

Clinical Guidelines & Evidence

Tokyo Guidelines 2018 (TG18) severity grading for acute cholangitis. Grade III (severe): any organ dysfunction. Grade II (moderate): no organ dysfunction but ≥2 of: WBC >12,000/<4,000, fever ≥39°C, age ≥75, bilirubin ≥5 mg/dL, albumin <0.7×LLN. Grade I (mild): neither.

Clinical Indication

The Tokyo Guidelines Cholangitis Severity (TG18) is indicated for bedside clinical practice to support Tokyo Guidelines 2018 (TG18) severity grading for acute cholangitis. Grade III (severe): any organ dysfunction. Grade II (moderate): no organ dysfunction but ≥2 of: WBC >12,000/<4,000, fever ≥39°C, age ≥75, bilirubin ≥5 mg/dL, albumin <0.7×LLN. Grade I (mild): neither.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.

Target Population

Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.

Limitations & Contraindications

Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.

Clinical Pearls & Action Plan

Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy.

Formula & Variables:

Grade III if any organ dysfunction; else Grade II if ≥2 predictors; else Grade I

Input Parameters

NameTypeRequiredDescription
organ_cardiovascularstringYesCardiovascular dysfunction (hypotension requiring vasopressors)
organ_neurologicalstringYesNeurological dysfunction (disturbance of consciousness)
organ_respiratorystringYesRespiratory dysfunction (PaO2/FiO2 ratio <300)
organ_renalstringYesRenal dysfunction (oliguria or creatinine >2.0 mg/dL)
organ_hepaticstringYesHepatic dysfunction (PT-INR >1.5)
organ_hematologicstringYesHematologic dysfunction (platelets <100,000/mm³)
wbc_abnormalstringYesWBC >12,000 or <4,000 per mm³
fever_ge_39stringYesFever ≥39°C
age_ge_75stringYesAge ≥75 years
bilirubin_ge_5stringYesTotal bilirubin ≥5 mg/dL
albumin_lowstringYesAlbumin <0.7× lower limit of normal

Score Interpretation & Guidance

RangeStageDescription
1–1Grade I (mild)Grade I (mild) acute cholangitis
2–2Grade II (moderate)Grade II (moderate) acute cholangitis
3–3Grade III (severe)Grade III (severe) acute cholangitis

Evidence-Based References (EBM)

  • Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis. J Hepatobiliary Pancreat Sci. 2018;25(1):17-30.

Related calculators